Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Celyad Sa ADR (NQ: CYAD ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, May 18, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Celyad Sa ADR < Previous 1 2 3 4 5 Next > Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007) September 07, 2023 From Celyad Oncology SA Via GlobeNewswire Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007) September 05, 2023 From Celyad Oncology SA Via GlobeNewswire Celyad Oncology Reports First Half 2023 Financial Results and Recent Business Highlights September 04, 2023 From Celyad Oncology SA Via GlobeNewswire Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholders August 24, 2023 From Celyad Oncology SA Via GlobeNewswire Celyad Oncology announces receipt of Nasdaq delisting notice May 15, 2023 From Celyad Oncology SA Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Pre-Market Session May 05, 2023 Via Benzinga Celyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From Nasdaq May 05, 2023 From Celyad Oncology SA Via GlobeNewswire Celyad Oncology reports first quarter 2023 financial results and recent business highlights May 05, 2023 From Celyad Oncology SA Via GlobeNewswire Celyad Oncology announces receipt of Nasdaq initial notification on ADS bid price April 24, 2023 From Celyad Oncology SA Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Intraday Session April 19, 2023 Via Benzinga Celyad Oncology announces receipt of Nasdaq notice April 04, 2023 From Celyad Oncology SA Via GlobeNewswire Celyad Oncology appoints Georges Rawadi as its new CEO March 24, 2023 From Celyad Oncology SA Via GlobeNewswire Celyad Oncology reports full year 2022 financial results and recent business highlights March 23, 2023 From Celyad Oncology SA Via GlobeNewswire Earnings Scheduled For March 23, 2023 March 23, 2023 Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter. Via Benzinga Celyad Oncology to announce full year 2022 financial results and host conference call March 17, 2023 From Celyad Oncology SA Via GlobeNewswire Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session March 16, 2023 Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session March 15, 2023 Via Benzinga Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 15, 2023 Gainers ThermoGenesis Holdings, Inc. (NASDAQ: THMO) shares jumped 80% to $3.7820 after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session March 15, 2023 Via Benzinga Why Jounce Therapeutics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket March 15, 2023 Gainers Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday March 15, 2023 We're beginning the day with a look at the biggest pre-market stock movers traders need to know about for Wednesday morning! Via InvestorPlace Celyad Oncology announces non-cash impairment March 15, 2023 From Celyad Oncology SA Via GlobeNewswire REPEAT -- Celyad Oncology SA - Letter to Shareholders March 01, 2023 From Celyad Oncology SA Via GlobeNewswire Celyad Oncology SA - Letter to Shareholders February 28, 2023 From Celyad Oncology SA Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Pre-Market Session February 23, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session February 20, 2023 Via Benzinga Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session February 17, 2023 Gainers Ibio Inc (NYSE: IBIO) shares rose 97% to $1.4787 after the company announced MUC16 as its latest immune-oncology target program. Via Benzinga Celyad Oncology announces the publication of data from its Phase 1 THINK study of CYAD-01 February 09, 2023 From Celyad Oncology SA Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's After-Market Session February 07, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session February 07, 2023 Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
